EANM Executive Secretariat, Hollandstrasse 14 / Mezzanine, 1020 Vienna, Austria
Phone: +43-(0)1-212 80 30, Fax: +43-(0)1-212 80 30-9, E-Mail: office@eanm.org
Programme
Scientific Programme
Symposia/Debates
Sunday, October 28, 2012 – Symposium 1
EANM/SNM Joint Session: Nuclear Medicine in Skeletal Disease(Chairs: A. Chiti, Milan & F.H. Fahey, Boston)
- Evaluating Skeletal Disease with PET/CT (G. Segall, Palo Alto)
- SPECT/CT Applications in Bone Scanning (G.L. Dillehay, Chicago)
- Paediatric Skeletal Imaging (F.H. Fahey, L. Drubach, Boston)
Sunday, October 28, 2012 – Symposium 2
EANM/LYSA-FIL Joint Session: The Role of PET/CT in the Treatment of Lymphoma (Chairs: S. Barrington, London & S.P. Mueller, Essen)
- PET in Hodgkin Lymphoma: A New Paradigm for Lymphoma Management (A. Gallamini, Cuneo)
- PET in Non Hodgkin Lymphoma: Different Approaches for Different Diseases (M. Meignan, Creteil)
- PET Reporting: Are we ready to Move from Clinical Trials to Daily Practice? (A. Biggi, Cuneo)
Sunday, October 28, 2012 – Symposium 3
New Developments in PET-Radiopharmaceutical Chemistry (Chairs: C. Halldin, Stockholm & P.H. Elsinga, Groningen)
- Downsizing Automation: Microfluidics and other Technologies (P.H. Elsinga, Groningen)
- New Opportunities in F-18 Chemistry (H.H. Coenen, Juelich)
- Increasing Versatility in C-11 Chemistry (M. Schou, Stockholm)
Sunday, October 28, 2012 – Symposium 4
EANM/EAU Joint Session: Diagnostics and Therapy in Patients with Biochemical Recurrence after Primary Therapy (Chairs: G. Janetschek, Salzburg & W. Langsteger, Linz)
- Introduction (G. Janetschek, Salzburg)
- PET/CT in Patients with Biochemical Recurrence after Primary Therapy (B.J. Krause, Rostock)
- Salvage Therapy Options: Urology (B. Tombal, Brussels)
- Salvage Therapy Options: Radiation Oncology (V. Khoo, London)
Sunday, October 28, 2012 – Symposium 5
EANM/ESR Joint Session: Diagnosis of Inflammatory Conditions (Chairs: A. Signore, Rome & A. Romero Jaramillo, Barcelona)
- Nuclear Medicine Imaging of IBD (J. Martin-Comin, Barcelona)
- Radiological Imaging of IBD (F. Maccioni, Rome)
- Nuclear Medicine Imaging of Infected Vascular Prosthesis (F. Jamar, Brussels)
- Radiological Imaging of Infected Vascular Prosthesis (A. Romero Jaramillo, Barcelona)
Monday, October 29, 2012 – Symposium 6
Current Legislation in Radiopharmacy in Europe(Chairs: J.F. Verzijlbergen, Rotterdam & C. Rossetti, Milan)
- Critical Issues in Radiopharmaceuticals Registration in Europe (J.F. Verzijlbergen, Rotterdam)
- Situation in Europe: The Main Differences (C. Decristoforo, Innsbruck)
- Preparation and Use of Radiopharmaceuticals: Role of National Regulators and Possible Harmonisation (A. Cortes Blanco, Madrid)
Monday, October 29, 2012 – Symposium 7
EANM/ESTRO Joint Session: Molecular Imaging of Hypoxia (Chairs: W.J.G. Oyen, Nijmegen & V. Gregoire, Brussels)
- The Relevance of Hypoxia for Tumour Response to Chemotherapy and Radiotherapy
(K. Haustermans, Leuven) - Radiopharmaceuticals for Imaging Hypoxia (P.J. Blower, London)
- Incorporation of Molecular Imaging of Hypoxia in Clinical Radiation Oncology (B. Gallez, Brussels)
Monday, October 29, 2012 – Symposium 8
Imaging to Select Appropriate Treatment in Cardiology (Chairs: I. Carrio, Barcelona & C. Marcassa, Veruno)
- Optimising Medical Treatment (J.M. Knuuti, Turku)
- Imaging in Revascularised Patients (W. Acampa, Naples)
- Adrenergic Imaging for Possible Indication of Implantable Cardioverter Defibrillator (ICD)
(N. Tamaki, Sapporo) - Indication of Cardiac Resynchronisation Therapy (CRT) (M.M. Henneman, Leiden)
Monday, October 29, 2012 – Symposium 9
Neuroinflammation (Chairs: J. Darcourt, Nice & U. Haberkorn, Heidelberg)
- Biology of Microglial Activation Illustrated by Optical Imaging (Presenter TBA)
- The Different PET and SPECT Radiopharmaceuticals for Neuroinflammation Imaging
(B. Tavitian, Orsay) - Neuroinflammation Imaging in Alzheimer’s Disease (S. Pappatà, Naples)
Tuesday, October 30, 2012 – Symposium 10
EANM/EORTC Joint Session: Functional Imaging Biomarkers: from the Bench to the Bedside(Chairs: I. Hristova, Brussels & F. Mottaghy, Aachen)
- Apoptosis Imaging in Oncology: Dead or Alive? (C. Van de Wiele, Ghent)
- Imaging of Caspase 3/7 Activation: from Bench to Bedside (E.O. Aboagye, London)
- The Importance of "Window" Studies (J.P. Machiels, Brussels)
Tuesday, October 30, 2012 – Symposium 11
Therapy of Liver Metastases(Chairs: L. Bodei, Milan & M. Ljungberg, Lund)
- Approved and Experimental Clinical Indications of Radioembolisation (M. Maccauro, Milan)
- Clinical Results (S. Ezziddin, Bonn)
- The Selection of the Administered Activity in Radioembolisation: Feasibility and Advantages of Dosimetry (L. Strigari, Rome)
Tuesday, October 30, 2012 – Symposium 12
Radiation Exposure(Chairs: M. Lassmann, Wuerzburg & T. Pfluger, Munich)
- Dosimetry and Effective Dose in NM Diagnostics (M. Lassmann, Wuerzburg)
- CT in Hybrid Systems (K. Bacher, Ghent)
- Paediatrics (A. Cortés Blanco, Madrid)
Wednesday, October 31, 2012 –
Symposium 13
New Frontiers of RIT in Haematologic and Solid Tumours(Chairs: M. Luster, Ulm & A. Gianni, Milan)
- Present and Future Approaches in Radioimmunotherapy (O.C. Boerman, Nijmegen)
- State of the Art in RIT of Haematologic and Solid Malignancies
(J.F. Chatal, F. Kraeber-Bodéré, Nantes) - How to Improve Dosimetry for RIT (G. Sgouros, Baltimore)
Wednesday, October 31, 2012 – Symposium 14
EANM/ESMI Joint Session: Tumour Metabolism - Imaging and Therapy(Chairs: B. Tavitian, Orsay & U. Haberkorn, Heidelberg)
- Metabolic Synthetic Lethality as a New Strategy for Cancer Therapy (C. Frezza, Cambridge)
- Metabolic Imaging in Mice with Mutations in Metabolic Pathways (B. Tavitian, Orsay)
- Imaging Tumour Metabolism with Hyperpolarised MRI (K.M. Brindle, Cambridge)
